메뉴 건너뛰기




Volumn 4, Issue 3, 2003, Pages 251-261

Therapeutic targets for metastatic prostate cancer

Author keywords

Antibody therapy; Caveolin 1; Gene therapy; HSV tk; Immunotherapy; Interleukin 12; RTVP 1

Indexed keywords

ADENOVIRUS VECTOR; ANDROGEN; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; B7 ANTIGEN; BEVACIZUMAB; CANCER VACCINE; CARBOPLATIN; CAVEOLIN 1; CETUXIMAB; DOXORUBICIN; ESTRAMUSTINE PHOSPHATE; GANCICLOVIR; GEFITINIB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMATINIB; INTERLEUKIN 12; J 591; MONOCLONAL ANTIBODY; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN ANTIBODY; PROTEIN INHIBITOR; PROTEIN P53; TRASTUZUMAB; TUMOR ANTIGEN; TYROSINE KINASE RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR;

EID: 0037380052     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033491127     Document Type: Review
Times cited : (21)

References (113)
  • 64
    • 0035988985 scopus 로고    scopus 로고
    • Nasto, B. (2002) Mol. Ther., 5, 652-653.
    • (2002) Mol. Ther. , vol.5 , pp. 652-653
    • Nasto, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.